Nineteen women with newly diagnosed ER+, low-grade breast cancer who were post-menopausal with at least 5 years from their last estrogen exposure were given 6mg/day of estradiol [28] for 7 to 14 days in the interval between diagnosis and surgery. The gene discussed is ESR1; the disease is breast cancer.